These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 17275129

  • 1. R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells.
    Behari J, Zeng G, Otruba W, Thompson MD, Muller P, Micsenyi A, Sekhon SS, Leoni L, Monga SP.
    J Hepatol; 2007 May; 46(5):849-57. PubMed ID: 17275129
    [Abstract] [Full Text] [Related]

  • 2. Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
    Maier TJ, Janssen A, Schmidt R, Geisslinger G, Grösch S.
    FASEB J; 2005 Aug; 19(10):1353-5. PubMed ID: 15946992
    [Abstract] [Full Text] [Related]

  • 3. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
    Suzui M, Masuda M, Lim JT, Albanese C, Pestell RG, Weinstein IB.
    Cancer Res; 2002 Jul 15; 62(14):3997-4006. PubMed ID: 12124333
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological inhibition of beta-catenin in hepatoblastoma cells.
    Ellerkamp V, Lieber J, Nagel C, Wenz J, Warmann SW, Fuchs J, Armeanu-Ebinger S.
    Pediatr Surg Int; 2013 Feb 15; 29(2):141-9. PubMed ID: 23266718
    [Abstract] [Full Text] [Related]

  • 5. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
    Li T, Zhong J, Dong X, Xiu P, Wang F, Wei H, Wang X, Xu Z, Liu F, Sun X, Li J.
    Oncol Rep; 2016 Jun 15; 35(6):3614-22. PubMed ID: 27109804
    [Abstract] [Full Text] [Related]

  • 6. Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines.
    Noda M, Tatsumi Y, Tomizawa M, Takama T, Mitsufuji S, Sugihara H, Kashima K, Hattori T.
    J Gastroenterol; 2002 Jun 15; 37(11):896-904. PubMed ID: 12483244
    [Abstract] [Full Text] [Related]

  • 7. Celecoxib inhibits β-catenin-dependent survival of the human osteosarcoma MG-63 cell line.
    Xia JJ, Pei LB, Zhuang JP, Ji Y, Xu GP, Zhang ZP, Li N, Yan JL.
    J Int Med Res; 2010 Jun 15; 38(4):1294-304. PubMed ID: 20926002
    [Abstract] [Full Text] [Related]

  • 8. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ, Chua MS, Wei W, So SK.
    Oncotarget; 2015 Oct 06; 6(30):29847-59. PubMed ID: 26359353
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors.
    Saito T, Tamura D, Asano R.
    Oncol Rep; 2014 Apr 06; 31(4):1637-44. PubMed ID: 24503782
    [Abstract] [Full Text] [Related]

  • 10. COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells.
    Cervello M, Bachvarov D, Cusimano A, Sardina F, Azzolina A, Lampiasi N, Giannitrapani L, McCubrey JA, Montalto G.
    OMICS; 2011 Jun 06; 15(6):383-92. PubMed ID: 21410330
    [Abstract] [Full Text] [Related]

  • 11. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2.
    Lim K, Han C, Dai Y, Shen M, Wu T.
    Mol Cancer Ther; 2009 Nov 06; 8(11):3046-55. PubMed ID: 19887546
    [Abstract] [Full Text] [Related]

  • 12. Celecoxib potentially inhibits metastasis of lung cancer promoted by surgery in mice, via suppression of the PGE2-modulated β-catenin pathway.
    Zhang S, Da L, Yang X, Feng D, Yin R, Li M, Zhang Z, Jiang F, Xu L.
    Toxicol Lett; 2014 Mar 03; 225(2):201-7. PubMed ID: 24374173
    [Abstract] [Full Text] [Related]

  • 13. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
    Sakoguchi-Okada N, Takahashi-Yanaga F, Fukada K, Shiraishi F, Taba Y, Miwa Y, Morimoto S, Iida M, Sasaguri T.
    Biochem Pharmacol; 2007 May 01; 73(9):1318-29. PubMed ID: 17270149
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
    Cui W, Yu CH, Hu KQ.
    Clin Cancer Res; 2005 Nov 15; 11(22):8213-21. PubMed ID: 16299255
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of tetrahydropyridinol derivatives on β-catenin signaling and invasion in human hepatocellular and breast carcinoma cells.
    Yadunandam AK, Yoon JS, Jeong YT, Kim WY, Lee SY, Kim GD.
    Int J Mol Med; 2015 Aug 15; 36(2):577-87. PubMed ID: 26059838
    [Abstract] [Full Text] [Related]

  • 16. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D.
    Mol Carcinog; 2009 Jan 15; 48(1):56-65. PubMed ID: 18506760
    [Abstract] [Full Text] [Related]

  • 17. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L, Wang X, Jia T, Wei W, Chua MS, So S.
    Oncotarget; 2015 Sep 22; 6(28):25390-401. PubMed ID: 26246473
    [Abstract] [Full Text] [Related]

  • 18. Nonsteroidal anti-inflammatory drugs diclofenac and celecoxib attenuates Wnt/β-catenin/Tcf signaling pathway in human glioblastoma cells.
    Sareddy GR, Kesanakurti D, Kirti PB, Babu PP.
    Neurochem Res; 2013 Nov 22; 38(11):2313-22. PubMed ID: 24013885
    [Abstract] [Full Text] [Related]

  • 19. Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.
    Chu TH, Chan HH, Kuo HM, Liu LF, Hu TH, Sun CK, Kung ML, Lin SW, Wang EM, Ma YL, Cheng KH, Lai KH, Wen ZH, Hsu PI, Tai MH.
    Oncotarget; 2014 Mar 30; 5(6):1475-90. PubMed ID: 24721996
    [Abstract] [Full Text] [Related]

  • 20. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
    Leng J, Han C, Demetris AJ, Michalopoulos GK, Wu T.
    Hepatology; 2003 Sep 30; 38(3):756-68. PubMed ID: 12939602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.